Geraldine A. Hamilton, PhD
Geraldine A. Hamilton is the President and Chief Scientific Officer of Emulate. Prior to joining Emulate’s founding team, she served as Lead Senior Staff Scientist with the Wyss Institute for Biologically Inspired Engineering at Harvard University. At the Wyss Institute, Hamilton lead the Organs-on-Chips program and managed the multidisciplinary team responsible for developing, translating and commercializing the Organs-on-Chips technology.
Hamilton’s carrier spans industry, academia and the start-up world. Prior to her tenure at Harvard University, Hamilton spent more than 11 years in the pharmaceutical industry in leadership roles managing drug discovery teams. Her research achievements helped advance the development and application of human relevant in vitro models for drug discovery. Hamilton was a founding scientist and VP of Scientific Operations for CellzDirect, a start-up biotech company that specialized in providing cell products to the pharmaceutical industry for safety testing. Hamilton was responsible for the successful translation of CellzDirect’s technology from academia to broad use and acceptance across the industry.
Hamilton received her Ph.D. in cell biology/toxicology from the University of Hertfordshire (England) in conjunction with GlaxoSmithkline, followed by a post-doctoral research fellowship at the University of North Carolina. She has authored more than 40 publications and numerous patents.